MSLN and familial pancreatic carcinoma: Xia et al. (2023) aimed to target this by using CAR-T cells directed against FAP, which has high levels of expression on CAFs, in a mouse model of pancreatic cancer followed by anti-MSLN CAR-T cells [167].